Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group (Q41743704)
Jump to navigation
Jump to search
scientific article published on April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group |
scientific article published on April 1998 |
Statements
1 reference
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group (English)
1 reference
A Goldhirsch
1 reference
A S Coates
1 reference
M Colleoni
1 reference
M Castiglione-Gertsch
1 reference
R D Gelber
1 reference
1 April 1998
1 reference
1 reference
16
1 reference
4
1 reference
1358-1362
1 reference
Identifiers
1 reference
1 reference